Volver al artículo.
Referencias para el artículo
- Jones AA, DiSilvestro RA, Coleman M, Wagner TL. Copper supplementation of
adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease
risk. Metabolism 1997;46:1380-3.
- Sandstead HH. Requirements and toxicity of essential trace elements,
illustrated by zinc and copper. Am J Clin Nutr 1995;61(suppl):62S–4S.
- Broun ER. Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A
reversible cause of sideroblastic anemia and bone marrow depression. JAMA
1990;264:1441–3.
- Jacob RA, Skala JH, Omaye ST, Turnlund JR. Effect of varying ascorbic acid
intakes on copper absorption and ceruloplasmin levels of young men. J Nutr
1987;117:2109–15.
- Aoyogi S, Baker DH. Bioavailability of copper in analytical-grade and
feed-grade inorganic copper sources when fed to provide copper at levels below the chicks
requirement. Poult Sci 1993;72:1075–83.
- Baker DH, Odle J, Funk MA, Wieland TM. Bioavailability of copper in cupric
oxide, cuprous oxide and in a copper-lysine complex. Poult Sci
1991;70:177–9.
- Cromwell GL, Stahly TS, Moneque HJ. Effects of source and level of copper on
performance and liver copper stores in weanling pigs. J Anim Sci
1989;67:2996–3002.
- Ledoux DR, Henry PR, Ammerman CB, et al. Estimation of the relative
bioavailability of inorganic copper sources for chicks using tissue uptake of copper. J
Anim Sci 1991;69:215–22.
- Baker DH. Cupric oxide should not be used as a copper supplement for either
animals or humans. J Nutr 1999;129:2278–9.
- Ford ES. Serum copper concentration and coronary heart disease among US
adults. Am J Epidemiol 2000;151:1182–8.
- Youssef A, Wood B, Baron DN. Serum copper: a marker of disease activity in
rheumatoid arthritis. J Clin Pathol 1983;36:14–17.